Detalhe da pesquisa
1.
The Impact of GLP-1 RAs and DPP-4is on Hospitalisation and Mortality in the COVID-19 Era: A Two-Year Observational Study.
Biomedicines
; 11(8)2023 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37626788
2.
Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy.
Diabetes Ther
; 14(12): 2127-2142, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801224
3.
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
Diabetes Ther
; 11(9): 1909-1914, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32749644